| Cameron J Britton, MD | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Cameron J Britton |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 5 Years |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588225254 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 29857 (Minnesota) | Secondary |
| 208800000X | Urology | 68020 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital Rochester | Rochester, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic | 6507778255 | 4232 |
News Archive
Local health departments in Northern Virginia, the District of Columbia and Maryland are investigating an outbreak of serious skin reactions among at least 16 women who have developed the condition after receiving cosmetic injections in October and November 2004.
The U.S. Food and Drug Administration have announced that a heart-failure drug manufactured for African-Americans significantly reduced deaths and hospitalizations and its side effects were similar to those of a placebo's.
More than 80 international medical graduates (IMGs) who have just earned a coveted medical residency placement came together this evening to celebrate their achievement with The Hon. Deb Matthews, Minister of Health and Long-Term Care.
Rhythm, a biotechnology company developing peptide therapeutics for metabolic diseases, today announced a study of obese primates treated with RM-493 showing a reversal of obesity and insulin resistance, and improvement in both heart rate and blood pressure. RM-493 is a novel peptide agonist targeting the melanocortin 4 receptor (MC4R) that is a clinical candidate for the treatment of obesity and diabetes.
Hospital resources and infrastructure dedicated to improving quality and safety are essential for achieving safe and high-quality surgical outcomes.
› Verified 9 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
Local health departments in Northern Virginia, the District of Columbia and Maryland are investigating an outbreak of serious skin reactions among at least 16 women who have developed the condition after receiving cosmetic injections in October and November 2004.
The U.S. Food and Drug Administration have announced that a heart-failure drug manufactured for African-Americans significantly reduced deaths and hospitalizations and its side effects were similar to those of a placebo's.
More than 80 international medical graduates (IMGs) who have just earned a coveted medical residency placement came together this evening to celebrate their achievement with The Hon. Deb Matthews, Minister of Health and Long-Term Care.
Rhythm, a biotechnology company developing peptide therapeutics for metabolic diseases, today announced a study of obese primates treated with RM-493 showing a reversal of obesity and insulin resistance, and improvement in both heart rate and blood pressure. RM-493 is a novel peptide agonist targeting the melanocortin 4 receptor (MC4R) that is a clinical candidate for the treatment of obesity and diabetes.
Hospital resources and infrastructure dedicated to improving quality and safety are essential for achieving safe and high-quality surgical outcomes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cameron J Britton, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: () - | Cameron J Britton, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
Local health departments in Northern Virginia, the District of Columbia and Maryland are investigating an outbreak of serious skin reactions among at least 16 women who have developed the condition after receiving cosmetic injections in October and November 2004.
The U.S. Food and Drug Administration have announced that a heart-failure drug manufactured for African-Americans significantly reduced deaths and hospitalizations and its side effects were similar to those of a placebo's.
More than 80 international medical graduates (IMGs) who have just earned a coveted medical residency placement came together this evening to celebrate their achievement with The Hon. Deb Matthews, Minister of Health and Long-Term Care.
Rhythm, a biotechnology company developing peptide therapeutics for metabolic diseases, today announced a study of obese primates treated with RM-493 showing a reversal of obesity and insulin resistance, and improvement in both heart rate and blood pressure. RM-493 is a novel peptide agonist targeting the melanocortin 4 receptor (MC4R) that is a clinical candidate for the treatment of obesity and diabetes.
Hospital resources and infrastructure dedicated to improving quality and safety are essential for achieving safe and high-quality surgical outcomes.
› Verified 9 days ago
Dr. Javier Piraino, D.O Urology Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
David E Patterson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Vidit Sharma, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Tobias Steen Kohler, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Paige Elizabeth Nichols, Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Anessa Naomi Sax-bolder, MD Urology Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Aaron Mark Potretzke, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |